Pure Global

AP-10 Blood Glucose Monitoring System - Taiwan Registration 1fa0e5b8c20ecd6ec630d8157c24fc1e

Access comprehensive regulatory information for AP-10 Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1fa0e5b8c20ecd6ec630d8157c24fc1e and manufactured by LEISON BIOTECH CO., LTD.. The authorized representative in Taiwan is LEISON BIOTECH CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1fa0e5b8c20ecd6ec630d8157c24fc1e
Registration Details
Taiwan FDA Registration: 1fa0e5b8c20ecd6ec630d8157c24fc1e
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

AP-10 Blood Glucose Monitoring System
TW: ๆธฌ็ณ–็ฉฉ่ก€็ณ–ๆธฌ่ฉฆ็ณป็ตฑ
Risk Class 2
MD

Registration Details

1fa0e5b8c20ecd6ec630d8157c24fc1e

Ministry of Health Medical Device Manufacturing No. 005994

Company Information

Taiwan, Province of China

Product Details

This product is intended for self-quantitative detection of fingertip microvascular whole blood and professional quantitative detection of glucose in venous whole blood blood.

A Clinical chemistry and clinical toxicology

A1345 Glucose Test System

Produced in Taiwan, China

Dates and Status

Aug 02, 2018

Aug 02, 2028